21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIAL INFECTIONS
#11702Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate
#11703BUFFERED COMPOSITIONS FOR DIALYSIS
#11704Systems, devices, and methods for making or administering frozen particles
#11705AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE
#11706TREATMENT OF ACNE DISEASE STATES, NOTABLY ACNE VULGARIS
#11707Use of rasagiline for the treatment of multiple system atrophy
#11708Pharmaceutical composition containing phloroglucinol and paracetamol
#11709PLANT EXTRACT COMPOSITION FOR TREATING HEPATITIS C
#11710THERAPEUTIC COMBINATION
#11711Pre-mixed, ready-to-use pharmaceutical compositions
#11712Combination of AMPA Receptor Antagonists and Acetylcholinesterase Inhibitors for the Treatment of Neuropathic Pain
#11713Method of Providing An Antihistaminic Effect in a Hepatically Impaired Patient
#11714Fat regulation
#11715Medicinal Compositions Comprising Buprenorphine And Naloxone
#11716COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS
#11717USE OF SUBSTITUTED QUINOLINE DERIVATIVES FOR THE TREATMENT OF DRUG RESISTANT MYCOBACTERIAL DISEASES
#11718COMPOSITIONS AND METHODS FOR MINIMIZING OR REDUCING AGONIST-INDUCED DESENSITIZATION
#11719Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect
#11720Pharmaceutical compounds
#117217,8,10,10A-TETRAHYDRO-6H-BENZO[C]CHROMEN-9(6AH)-ONE MODULATORS OF CANNABINOID RECEPTORS
#11722Dopamine and agonists and antagonists thereof for modulation of suppressive activity of CD4+CD25+ regulatory T cells
#11723Therapeutic compounds and related methods of use
#11724Heterobicyclic carboxamides as inhibitors for kinases
#11725Drug Combinations for the Treatment of Duchenne Muscular Dystrophy
#11726EXTENDED ESTROGEN DOSING CONTRACEPTIVE REGIMEN
#11727ORAL DELIVERY SYSTEM FOR METHYLCOBALAMIN TO TREAT DISORDERS
#11728Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation
#11729METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES
#11730Treatment of stroke using domain V of perlecan
#11731HUMAN CANCER THERAPY USING ENGINEERED MATRIX METALLOPROTEINASE-ACTIVATED ANTHRAX LETHAL TOXIN THAT TARGETS TUMOR VASCULATUTURE
#11732Methods and compositions for the synergistic activation of latent HIV
#11733Pharmaceutical formulations comprising an insulin derivative
#11734ISOPROPOXYPHENYLMETHYL INHIBITORS OF SGLT2
#11735ETHOXYPHENYLMETHYL INHIBITORS OF SGLT2
#11736Methods and pharmaceutical compositions for healing wounds
#11737Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
#11738VACCINE AGAINST INFECTIOUS AGENTS HAVING AN INTRACELLULAR PHASE, COMPOSITION FOR THE TREATMENT AND PREVENTION OF HIV INFECTIONS, ANTIBODIES AND METHOD OF DIAGNOSIS
#11739PLATELET STABILIZATION
#11740Nutraceuticals containing nitro fatty acids
#11741Herbal composition for reducing ADD/ADHD and method thereof
#11742Herbal composition PHY906 and its use in chemotherapy
#11743Composition comprising hemp oil for treating topical diseases, especially hand-foot syndrome
#11744Composition and method for the control of organoleptic properties of bodily fluids and secretions
#11745DIBENZO[b,e][1,4]DIAZEPINE MODULATORS OF DOPAMINE RECEPTORS, SEROTONIN RECEPTORS, ADRENERGIC RECEPTORS, ACETYLCHOLINE RECEPTORS, AND/OR HISTAMINE RECEPTORS
#11746METHODS OF TREATING THE SKIN
#11747Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-A] pyridine-3-yl-2,5-Dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine
#11748Compositions for accelerating the production of collagen-containing proteins
#11749Composition comprising egg white combined chalcanthite for preventing or treating cancer
#11750METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION
#11751Administration form of osteogenic protein complexes
#11752Medicine for treating gastrointestinal disorder including acquired lactose-intolerance irritable bowel syndrome
#11753PHARMACEUTICAL COMPOSITION IN THE FORM OF COATED MICROSPHERES FOR THE MODIFIED RELEASE OF A MUSCLE RELAXANT AND AN NSAID
#11754LIPOSOMAL FORMULATIONS FOR TREATING CANCER
#11755MANAGEMENT OF MYOCLONUS WITH ORAL LIPOSOMAL REDUCED GLUTATHIONE
#11756EXTRACELLULAR MATRIX COMPOSITIONS
#11757Methods for reducing the incidence of mastitis
#11758Adenoviral vectors and methods and uses related thereto
#11759CLIP INHIBITORS AND METHODS OF MODULATING IMMUNE FUNCTION
#11760Toll-like receptor 3 antagonists
#11761Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
#11762High affinity human antibodies to PCSK9
#11763Transferrin receptor antibodies
#11764Immunostimulatory oligonucleotide multimers
#11765METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS
#11766Liquid, Aqueous Pharmaceutical Composition of Factor VII Polypeptides
#11767Modified factor VII polypeptides and uses thereof
#11768S-Adenosylmethionine And Methylthioadensosine In Chemoprevention And Treatment Of Colon Polyps And Cancer
#11769Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof
#11770METHOD FOR TREATING RENAL CELL CARCINOMA USING GLYCOGENOLYSIS INHIBITORS
#11771Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
#11772NEW COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION
#11773Method of treating cancer by combination therapy using TNF and alpha-galactosylceramide
#11774AMIDO-AMINE DENDRIMER COMPOSITIONS
#11775Method of ameliorating symptoms of type 1-diabetes using GABA related compounds and GLP-1/exendin-4 compounds
#11776ORGANIC COMPOUNDS
#11777Method to inhibit cancer targeting CD24
#11778Systems, devices, and methods for making or administering frozen particles
#11779Synergistic Mixtures of OPP and DGH
#11780Methods and Compositions for the Treatment of Viral Infections
#11781Anti-bacterial plant compositions
#11782METHOD OF TREATING VASCULAR INJURIES INDUCED BY AN EXCESS OF PLASMA LIPIDS USING COMBINATIONS OF VASOPROTECTIVE AGENTS
#11783Bisbenzimidazoles as antimalarial agents
#11784TREATMENT OF PROTEINOPATHIES USING A FARNESYL TRANSFERASE INHIBITOR
#11785PHARMACEUTICAL COMPOSITIONS CONTAINING PYRROLOQUINOLINE QUINONE AND NEPHROPROTECTANT FOR TREATING ISCHEMIA REPERFUSION INJURIES
#11786TREATMENT METHOD
#11787TREATMENT OF MAJOR ADVERSE CARDIAC EVENTS AND ACUTE CORONARY SYNDROME USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR OR SPLA2 INHIBITOR COMBINATION THERAPIES
#11788PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HYPERURICEMIA AND RELATED DISORDERS
#11789Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#11790Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#11791Method of treating ocular allergy
#11792TREATMENT OF RESTLESS LEG SYNDROME AND SLEEP DISORDERS
#11793TOLERABILITY OF MIRTAZAPINE AND A SECOND ACTIVE BY USING THEM IN COMBINATION
#11794Pharmaceutical composition for treating Alzheimer's disease
#11795Carbapenem antibacterials with gram-negative activity and processes for their preparation
#11796Compositions for combating beta-lactamase-medicated antibiotic resistance using beta-lactamase inhibitors useful for injection
#11797Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
#11798Use of testosterone and a 5-HT1a agonist in the treatment of sexual dysfunction
#11799Use of HDAC inhibitors for the treatment of myeloma
#11800Treatment for epilepsy
#11801ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN
#11802Synergetic Effects of HGF and Antibacterial Treatment
#11803Pharmaceutical composition
#11804Combinations of herb extracts having synergistic antioxidant effect, and methods relating thereto
#11805Synergistic antioxidant combinations of herb extracts and methods relating thereto
#11806USE AS A MEANS TO IMPROVE FERTILITY OF A PHYTOTHERAPEUTIC COMPOSITION AND METHOD FOR IMPROVING AND/OR PROMOTING FERTILITY HEALTH
#11807KIT FOR TREATING SKIN INFECTION
#11808PYRROLIDINONE INHIBITORS OF PDE-4
#11809BENZISOXAZOLE MODULATORS OF D2 RECEPTOR, AND/OR 5-HT2A RECEPTOR
#11810COMBINATIONS USEFUL FOR THE TREATMENT OF NEURONAL DISORDERS
#11811Nail fungus treatment and composition
#11812METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TURMORGENICITY
#11813COMPOSITION AND NUTRITIONAL SUPPLEMENTS FOR IMPROVING OCULAR HEALTH AND REDUCING OCULAR INFLAMMATORY RESPONSE
#11814Colonic purgative composition with soluble binding agent
#11815Small Molecule Ligands of the Integrin RGD Recognition Site and Methods of Use
#11816COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS
#11817METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS
#11818COMBINATION OF TRIAZINE DERIVATIVES AND HMG-COA REDUCTASE INHIBITORS
#11819Adhesive Label With Bittering Agent and Fluidifying Agents for Natural Airway Secretions
#11820Encapsulates
#11821METHOD FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN A SUBJECT IN NEED THEREOF
#11822METHOD FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN A SUBJECT IN NEED THEREOF
#11823SELENIUM-BASED BIOCIDAL FORMULATIONS AND METHODS OF USE THEREOF
#11824SELENIUM-BASED BIOCIDAL FORMULATIONS AND METHODS OF USE THEREOF
#11825Immunostimulatory compositions and methods
#11826Fully human antibodies directed against the human insulin-like growth factor-1 receptor
#11827KLOTHO BETA
#11828COMBINATION THERAPY OF ARTHRITIS WITH TRANILAST
#11829PAI-1 MODULATORS FOR THE TREATMENT OF OCULAR DISORDERS
#11830METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS
#11831Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
#11832Therapeutic composition produced using punica granatum and hydrogen peroxide
#11833Treating idiopathic thrombocytopenic purpura with comprising extracts of
#11834ADMINISTRATION OF CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISEASES
#11835DENDRIMER BASED MODULAR PLATFORMS
#11836Systems, devices and methods for making or administering frozen particles
#11837Frozen compositions and methods for piercing a substrate
#11838Methods of treatment of hyperuricemia and associated disease states
#11839Flavononol Renin Inhibitor Compounds and Methods of Use Thereof
#11840Drug or Supplement Combination with Conjugated Linoleic Acid for Fat Loss in Mammals
#11841Estrogen receptor modulators and uses thereof
#11842STABLE ATORVASTATIN FORMULATIONS
#11843Compositions and methods for the treatment of overactive bladder
#11844BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ONDANSETRON
#11845Medicinal compositions comprising buprenorphine and nalmefene
#11846Pharmaceutical composition
#11847USE OF C-SRC INHIBITORS IN COMBINATION WITH A PYRIMIDYLAMINOBENZAMIDE COMPOUND FOR THE TREATMENT OF LEUKEMIA
#11848COMPOSITIONS FOR WEIGHT MANAGEMENT
#11849Use of 3-alpha-androstanediol in combination with a PDE5 inhibitor, in the treatment of sexual dysfunction
#11850Methods of treating skin disorders with caffeic acid analogs
#11851Use of chitosans to increase nail growth rate
#11852Method for producing purified hematinic iron-saccharadic complex and product produced
#11853TREATMENT OF CANCER WITH GLUTAMINE
#11854Novel synergistic combination of gemcitabine with P276-00 or P1446A in treatment of cancer
#11855Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B
#11856Oligo-guluronate and galacturonate compositions
#11857METHODS AND COMBINATION THERAPIES FOR TREATING ALZHEIMER'S DISEASE
#11858LONG-TERM FEED - CANCER PATIENT
#11859ACCELERATED THERAPY
#11860Methods for the treatment of infections and tumors
#11861COMPOSITION FOR SUPPRESSING APPETITE, IMPROVING TONE AND MOOD, WITH A NATURAL ANTIDEPRESSANT ACTIVITY AND WITH AN ANTIASTHENIC EFFECT
#11862METHODS OF USING BENFOTIAMINE AND PYRIDOXAMINE COMPOSITIONS
#11863Compositions for producing satiety
#11864Anti-tumor drug, medicament, composition, and use thereof
#11865Topical composition and method for the treatment and prophylaxis of dermal irritations
#11866COMPOSITION AND METHOD FOR REDUCING SIDE-EFFECTS OF INDOLE-3-CARBINOL AND DERIVATIVES
#11867USE OF ISOOSMOTIC SEAWATER-BASED IONIC SOLUTIONS FOR MANUFACTURING MEDICAL DEVICES FOR THE PREVENTION OF COMPLICATIONS OF THE COMMON COLD OR OF THE FLU SYNDROME
#11868Materials and Methods for Treating Influenza Infections
#11869Silver and Zinc Containing Body Care Agent
#11870PREVENTION AND TREATMENT FOR OSTEONECROSIS AND OSTEORADIONECROSIS OF THE JAW
#11871Time delayed release mechanism for energizing composition and method of use
#11872Gastric acid secretion inhibiting composition
#11873Cancer therapy sensitizer
#11874MODULATION OF DRUG SENSITIVITY
#11875Treatment of arthritis with parathyroid hormone
#11876ATHLETIC PATCH
#11877Film preparation with rapidly dissolving property and flexibility
#11878Oral care product
#11879Administration of Enoxoparin Sodium to Patients 75 Years and Older With ST-Segment Elevation Myocardian Infarction
#11880TOLERANCE INDUCTION AND MAINTENANCE IN HEMATOPOIETIC STEM CELL ALLOGRAFTS
#11881METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF DEPRESSION AND ANXIETY
#11882Anti-IGF antibodies
#11883Method of treating rash in patients undergoing anti-EGFR therapy
#11884Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus
#11885METHODS OF TREATING MULTIPLE SCLEROSIS BY ADMINISTRATION OF ALPHA-FETOPROTEIN IN COMBINATION WITH AN INTEGRIN ANTAGONIST
#11886Compositions and methods for enzymatic treatment of lung disorders
#11887DIAMINOQUINAZOLINE INHIBITORS OF DIHYDROFOLATE REDUCTASE
#11888Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease
#11889Methods and compositions for treating autoimmune diseases
#11890Administration of stem or progenitor cells to a joint to enhance recovery from joint surgery
#11891Anticancer Agent to Be Combined with Telomelysin
#11892Compositions and Methods for Use of Scar Tissue in Repair of Weight Bearing Surfaces
#11893Use of α-glucosidase inhibitors to treat alphavirus infections
#11894NOVEL FORMULATIONS TO INHIBIT CYCLOOXYGENASE AND PRO-INFLAMMATORY CYTOKINE MEDIATED DISEASES
#11895Compositions with enhanced bioavailability and fast acting inhibitor or gastric acid secretion
#11896METHOD OF TREATING CANCER
#11897HISTONE ACETYL TRANSFERASE ACTIVATORS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF ALCOHOLISM
#11898Use of a PPARalpha Agonist and Metformin for Decreasing the Serum Triglycerides
#11899NOVEL COMBINED ADMINISTRATION
#11900METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF
#11901Methods for modulating the efficacy of nucleic acid based therapies
#11902Combination of organic compounds useful for treating diabetes
#11903AEROSOL FORMULATION
#11904Method of network-based identification of multicomponent synergy and compositions for use as effective component of anti-angiogenesis medicines
#11905Methods and compositions for treating or preventing narcotic withdrawal symptoms
#11906Crystal modifications of transmission dyes
#11907Combination medicaments for treating bacterial infections
#11908PHARMACEUTICAL COMPOSITIONS CONTAINING TESTOSTERONE AND AN AROMATASE INHIBITOR
#11909Inhibiting cyclin D polypeptides
#11910Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
#11911METHODS FOR GENERATING MAMMALIAN MODELS OF ATOPIC DISEASES, AND SCREENING FOR THEIR TREATMENT
#11912USE OF N,N-DIETHYL-2-[-4-(PHENYLMETHYL)-PHENOXY]ETHANAMINE MONOHYDROCHLORIDE (DPPE) IN CANCER THEREAPY
#11913Targeting agent for cancer cell or cancer-associated fibroblast
#11914Antibiotics, bispolides A1, A2, and A3 as well as bispolides B1, B2a, B2b and B3 and processes for producing said antibiotics
#11915COMPOSITION COMPRISING A GLYCOLYTIC INHIBITOR AND A RING SYSTEM COMPRISING A SULPHAMATE GROUP FOR THE TREATMENT OF CANCER
#11916Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
#11917Treatment of Multi-Drug Resistant Bacterial Infections
#11918Process for the preparation of compositions of AT1 receptor antagonist and Angiotensin—(1-7)
#11919Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen
#11920Combined use of DPP-IV Inhibitors and Gastrin Compounds
#11921Treatment of T-cell mediated diseases
#11922COMBINATION 408
#11923RESCUE OF GONADOTROPIN RELEASING HORMONE RECEPTOR MUTANTS
#11924Compositions comprising physiologic concentrations of cytokines
#11925METHODS AND USES THEREOF OF PROSAPOSIN
#11926Methods of Inhibiting Metastatic Cancer by Administration of Streptolysin O
#11927Natural polypeptides for oral health care
#11928Novel combinatorial approaches to enhancing oxygen transport to tissues
#11929BENZIMIDAZOLE DERIVATIVES AND METHODS OF USE THEREOF
#11930NUTRITIONAL SUPPLEMENT FORMULATIONS FOR INCLUSION IN FOODS AND FORTIFIED FOODS COMPRISING SUCH SUPPLEMENTS
#11931CARBOXYLIC ACID INHIBITORS OF HISTONE DEACETYLASE, GABA TRANSAMINASE AND SODIUM CHANNEL
#11932INDANONE INHIBITORS OF ACETYLCHOLINESTERASE
#11933Compositions and methods for cardiac tissue protection and regeneration
#11934COMBINATIONS OF NITRIC OXIDE AND SULFIDE AND METHODS OF USE AND MANUFACTURE THEREOF
#11935SOLID COMPOSITION COMPRISING A CLAY SUCH AS KAOLIN
#11936Methods and Compositions for Inhibiting GSK-3 In Glial Cell Related Disorders
#11937OPHTHALMIC SOLUTIONS
#11938Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions
#11939NOVEL REDUCED DOSE PHARMACEUTICAL COMPOSITIONS OF FEXOFENADINE AND PSEUDOEPHEDRINE
#11940CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING THIAZIDES AND ANGIOTENSIN-II-RECEPTOR BLOCKERS
#11941Pharmaceutical compositions
#11942ANALGESIC COMPOSITION OF TOPICALLY APPLIED NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND OPIOIDS
#11943Dermatological/cosmetic skin depigmenting compositions
#11944ORAL CARE PRODUCT
#11945Compositions and methods for controlling diseases in animals
#11946Synergistic phytoceutical compositions
#11947Synergistic phytoceutical compositions
#11948MIF AGONISTS AND ANTAGONIST AND THERAPEUTIC USES THEREOF
#11949ANTITUMOR AGENT
#11950Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same
#11951COMBINATION THERAPY FOR B CELL DISORDERS
#11952Anti-Angiogenesis Therapy for the Treatment of Breast Cancer
#11953Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders
#11954Treatment of Macular Degeneration
#11955METHODS AND COMPOSITIONS FOR TREATING CANCER
#11956Treatment of T-cell mediated diseases
#11957T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation
#11958Injection of fibrin sealant including an anesthetic in spinal applications
#11959Composition And Methods Involving Thrombolytic Agents
#11960Infarct area perfusion-improving compositions and methods of vascular injury repair
#11961Viral vectors
#11962METHODS OF ENHANCING LYSOSOMAL STORAGE DISEASE THERAPY BY MODULATION OF CELL SURFACE RECEPTOR DENSITY
#11963PODOPHYLLOTOXIN INHIBITORS OF TOPOISOMERASE II
#11964QUINAZOLINE INHIBITORS OF EGFR TYROSINE KINASE
#11965T cell activation
#11966UMBILICAL CORD STEM CELL SECRETED PRODUCT DERIVED TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF
#11967TRIFLUOROMETHYLPHENYL MODULATORS OF CALCIUM-SENSING RECEPTOR
#11968Dermatological/pharmaceutical compositions comprising benzoyl peroxide, at least one naphthoic acid compound and at least one polyurethane polymer
#11969PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ASTHMA
#11970Methods for reducing allergies caused by environmental allergens
#11971Prevention of Cancers by Immunization
#11972Frozen compositions and methods for piercing a substrate
#11973Delivery devices for modulating inflammation
#11974Delivery devices for modulating inflammation
#11975Injection of fibrin sealant including an anesthetic in spinal applications
#11976Delivery devices for modulating inflammation
#11977Peptidomimetic protease inhibitors
#11978USE OF ONE OR MORE METAL CARRIERS TO SELECTIVELY KILL MAMMALIAN CELLS
#11979Compositions and methods for treating hoof diseases
#11980SUBSTITUTED 1,3-CYCLOPENTADIONE MULTI-TARGET PROTEIN KINASE MODULATORS OF CANCER, ANGIOGENESIS AND THE INFLAMMATORY PATHWAYS ASSOCIATED THEREWITH
#11981Composition for inactivating an enveloped virus
#11982Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
#11983Softgel of NLKJ for treating prostate diseases
#11984METHOD FOR ENHANCING COGNITION OR INHIBITING COGNITIVE DECLINE
#11985PREVENTIVE AND/OR THERAPEUTIC AGENT FOR URINE COLLECTION DISORDER ACCOMPANYING LOWER URINARY TRACT OBSTRUCTION
#11986Therapy for the treatment of disease
#11987Anthelmintic composition
#11988PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#11989Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
#11990Bicyclic heterocyclic compound
#11991COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL
#11992Methods and Compositions for Ameliorating Thiazide Induced Hyperlipidemia
#11993Compositions for the Treatment and Prevention of Heart Disease and Methods of Using Same
#11994PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS
#11995PHTHALAZINONE MODULATORS OF H1 RECEPTORS AND/OR LTC4 RECEPTORS
#11996FORMULATIONS FOR TREATMENT OF ADIPOSE TISSUE, CUTANEOUS TISSUE AND DISORDERS, AND MUSCULAR TISSUE
#11997TREATMENT OF INSULIN RESISTANCE AND DISORDERS ASSOCIATED THEREWITH
#11998Treatment of conditions relating to hormone deficiencies by administration of progestins
#11999Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
#12000Ophthalmic composition